Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDConstellation Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/10/2021 | Q1 2021 | -$0.79 | -$0.84 | -0.05 | $0 | |
| 02/24/2021 | Q4 2020 | -$0.76 | -$0.79 | -0.03 | $0 | |
| 10/29/2020 | Q3 2020 | -$0.68 | -$0.71 | -0.03 | $0 | |
| 08/05/2020 | Q2 2020 | -$0.63 | -$0.70 | -0.07 | $0 | |
| 05/06/2020 | Q1 2020 | -$0.62 | -$0.61 | 0.01 | $0 | |
| 03/10/2020 | Q4 2019 | -$0.69 | -$0.58 | 0.11 | $0 | |
| 11/06/2019 | Q3 2019 | -$0.83 | -$0.82 | 0.01 | $0 | |
| 08/07/2019 | Q2 2019 | -$0.81 | -$0.80 | 0.01 | $0 | |
| 05/08/2019 | Q1 2019 | -$0.80 | -$0.75 | 0.05 | $0 | |
| 03/14/2019 | Q4 2018 | -$0.73 | -$0.77 | -0.04 | $0 | |
| 11/08/2018 | Q3 2018 | -$0.67 | -$0.81 | -0.14 | $0 | |
| 08/13/2018 | Q2 2018 | -$0.71 | -$0.44 | 0.27 | $0 | |
| 03/30/2018 | Q1 2018 | -$0.93 | $0 | |||
| 12/30/2017 | Q4 2017 | -$9.95 | $0 | |||
| 09/29/2017 | Q3 2017 | -$8.16 | $0 | |||
| 06/29/2017 | Q2 2017 | -$6.66 | $0 | |||
| 03/30/2017 | Q1 2017 | -$4.73 | $0 |
Constellation Pharmaceuticals, Inc. Earnings: FAQ's
When is Constellation Pharmaceuticals, Inc.'s earnings date?
Constellation Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 3rd, 2021 based off last year's report dates.
How can I listen to Constellation Pharmaceuticals, Inc.'s earnings conference
call?
The conference call for Constellation Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
How can I read Constellation Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Constellation Pharmaceuticals, Inc.'s latest earnings report can be read online.
How much profit does Constellation Pharmaceuticals, Inc. generate each year?
Constellation Pharmaceuticals, Inc. (:CNST) has a recorded net income of $0. Constellation Pharmaceuticals, Inc. has generated $-4.49 earnings per share over the last four quarters.
What is Constellation Pharmaceuticals, Inc.'s price-to-earnings ratio?
Constellation Pharmaceuticals, Inc. (:CNST) has a price-to-earnings ratio of -7.57 and price/earnings-to-growth ratio is -0.08.